Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics. The lead drug is a formulation of doxorubicin, the ...
The family of a Bridgeport man killed nearly one year ago was in court Thursday as his alleged killer went before a judge for the first time. Azaya Stefurak, 21, of Bridgeport, appeared before a judge ...
BRIDGEPORT — A local man was sentenced Tuesday to 35 years in prison for fatally shooting the father of a 6-year-old girl behind an East Main Street apartment building two years ago. Azaya “Lil Zay” ...
BRIDGEPORT — A suspect in a fatal shooting more than a year old was apprehended by federal officials Wednesday, according to local police Azaya Stefurak, 21, of Bridgeport, was charged by warrant with ...
The Texas Emerging Technology Fund will invest $1 million in Azaya Therapeutics Inc. to help the company commercialize a new treatment for fighting cancerous tumors. San Antonio-based Azaya will use ...
Azaya Therapeutics Inc., a clinical-stage oncology company, has entered into an exclusive licensing agreement with CANbridge Life Sciences, which will develop and commercialize the San Antonio-based ...
Cytori Therapeutics Inc. stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms ...
* Azaya Therapeutics Inc reports 5 percent passive stake in Cytori Therapeutics as on Feb. 15, 2017 Source text: Further company coverage: ...
Azaya Therapeutics, Inc. announced that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead product “ATI-1123,” a novel and improved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results